Vascular endothelial growth factor and poor prognosis after ischaemic stroke

@article{Escudero2020VascularEG,
  title={Vascular endothelial growth factor and poor prognosis after ischaemic stroke},
  author={Carlos Escudero and Jesenia Acurio and EDUARDO LOPEZ and Andr{\'e}s Rodr{\'i}guez and Antonia Benavente and Evelyn Lara and Steven J. Korzeniewski},
  journal={European Journal of Neurology},
  year={2020},
  volume={28}
}
Systemic inflammation conveys information about ischaemic stroke prognosis. Growth factors with neurotrophic and angiogenesis‐regulating properties might provide additional information about sequelae. The prognostic performance of circulating vascular endothelial growth factor (VEGF), placental growth factor, interleukin 6 and C‐reactive protein measured after acute ischaemic stroke was evaluated. 

How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?

TLDR
A hypothesis is provided of how sFlt-1 could eventually be a protective factor for brain endothelial cells of the BBB under preeclampsia, and this compartmentalization of VEGF signaling could help to see in a different viewpoint the role of sFolt-1 in the development of endothelial dysfunction.

Exosome in Crosstalk between Inflammation and Angiogenesis: A Potential Therapeutic Strategy for Stroke

TLDR
The exosomes in complex interaction mechanisms of angiogenesis and inflammation following stroke as well as the challenges of exosomal studies such as secretion, uptake, modification, and application are discussed.

Effect of Normobaric Hyperoxia Preconditioning on VEGF and Endostatin Levels in the Rat Stroke Model

TLDR
It is shown that normobaric hyperoxia (HO) protects the rat brain from ischemia injury by changing in VEGF and endostatin levels, which may have a role in neuroprotective effects.

From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment

TLDR
The oxidative stress and inflammatory processes in the back of the eye, the importance of biomarkers, detected in systemic or ocular fluids, for the diagnosis of eye diseases based on recent studies, and the treatment of posterior ocular diseases, based on long-term clinical studies are analyzed.

From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment

TLDR
The oxidative stress and inflammatory processes in the back of the eye, the importance of biomarkers, detected in systemic or ocular fluids, for the diagnosis of eye diseases based on recent studies, and the treatment of posterior ocular diseases, based on long-term clinical studies are analyzed.

References

SHOWING 1-10 OF 29 REFERENCES

Circulating levels of vascular endothelial growth factor and post‐stroke long‐term functional outcome

TLDR
Serum VEGF (s‐VEGF) in the acute stage and 3 months post‐stroke in relation to stroke severity and functional outcome is investigated.

Serum VEGF levels in acute ischaemic strokes are correlated with long‐term prognosis

TLDR
This investigation investigated whether serum vascular endothelial growth factor levels in acute‐stage ischaemic stroke patients with small vessel disease or large vessel disease are correlated with long‐term prognoses, based on the difference in NIH Stroke Scale (NIHSS) scores between acute and chronic stages.

Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke

TLDR
VEGF and endostatin may mediate EPCs proliferation in the early phase of ischemic stroke, and the circulating EPCS levels can be a predictor of clinical outcome in AIS, according to ROC curve analysis.

The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.

TLDR
It is concluded that the concentration of Il-6 and S100B on the first day of stroke are important for both the neurological status and the functional status in the acute period of the disease.

Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke

Background An imbalance between circulating neuroprotective and neurotoxic T cell subsets leads to poor prognosis in acute ischaemic stroke (AIS). Preclinical studies have indicated that the soluble

Nerve growth factor: a neuroimmune crosstalk mediator for all seasons

TLDR
NGF exerts a modulatory role on sensory nociceptive nerve physiology in the adult, which appears to correlate with hyperalgesic phenomena occurring in tissue inflammation, and can be viewed as a multifactorial modulator of neuro–immune–endocrine functions.

Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

TLDR
High serum levels of VEGF, Ang-1, G-CSF, and SDF-1α at day 7 and 3 months after ischemic stroke are associated with good functional outcome and smaller residual lesion at 1 year of follow-up.

Cell Type‐Specific Expression of Neuropilins in an MCA‐Occlusion Model in Mice Suggests a Potential Role in Post‐Ischemic Brain Remodeling

TLDR
The results suggest a shift in the balance between semaphorins and VEGF/PLGF, which compete for NP-binding, thus inducing angiogenesis and suggesting a neurotrophic/neuroprotective role of V EGF/ PLGF.

Placental growth factor deficiency is associated with impaired cerebral vascular development in mice.

TLDR
It is suggested that local PGF has a more important role than distant maternal or placental sources in cerebrovascular development, as PGF was strongly expressed in the developing brain at all timepoints.